Deep Tech Startups

Anaphite develops DCP®, a dry coating powder technology platform, for use in applications such as solid-state batteries and silicon anodes.

7 investors

ANELLO Photonics develops silicon photonics-based inertial navigation systems, specifically its SiPhOG platform, which delivers optical gyroscope performance in a chip-scale form factor for GPS-denied environments. The company serves defense, autonomous systems, and commercial markets requiring resilient navigation in contested or GPS-denied conditions across land, air, and sea operations.

7 investors

Ansa provides an enzymatic DNA synthesis platform that directly synthesizes complex sequences up to 900 bp and delivers constructs up to 50 kb without assembly-based methods. It serves scientists in gene and cell therapies, antibody discovery, CDMOs, and agrigenomics.

7 investors

Anthrogen develops Odyssey, a family of protein language models with 102 billion parameters designed for multi-objective protein design. The models provide an API for researchers and organizations in biotechnology and drug discovery.

7 investors

Applied Atomics develops space launch and test infrastructure for commercial rocket companies. The company provides launch sites and related hardware services for the emerging commercial space sector.

7 investors

ARX Robotics develops robotics and sensor systems, with a stated focus on defense applications that protect people and support European sovereignty and security.

7 investors

Atomic.ai combines machine learning and RNA biology to discover and develop RNA-based drugs. The company applies computational approaches to advance RNA therapeutics.

7 investors

Atomionics builds quantum sensors based on cold atom interferometry that generate 3D models of the Earth's subsurface to locate critical resources, enable GPS-free navigation, and detect seismic and volcanic activity. The company operates at the intersection of quantum physics, hardware, and AI.

7 investors

Avalanche Energy develops compact fusion technology to generate high-energy neutrons for materials testing, radioisotope production, and advanced nuclear battery systems serving defense, space, and commercial power applications. The company also provides high-voltage vacuum components and operates FusionWERX, a commercial-scale fusion testing facility.

7 investors

Berkeley Lights (now Bruker Cellular Analysis) develops the Beacon optofluidic system for single-cell functional analysis, enabling researchers to profile live single cells to discover therapeutic antibodies, interrogate T cells, identify cell therapies, and accelerate cell line development. Its platform serves biotech, pharma, and academic researchers across discovery, basic research, and translational research.

7 investors

bitBiome provides contract analysis and collaborative research using single-cell genome sequencing technology for microbial samples. The company serves clients in biotech and related manufacturing sectors in Japan and the U.S.

7 investors

BosonQ Psi (BQP) develops BQPhy, a simulation software that integrates quantum computing with high-fidelity engineering simulations such as computational fluid dynamics. The company builds tools for engineering and computational analysis, drawing on expertise in quantum computing, CFD, and related emerging technologies.

7 investors

Cache develops a platform for reliable long-term storage and access of biomolecules to support precision medicine and fundamental research. It aims to provide scalable, sustainable, and standardized biomolecule storage.

7 investors

Carbon Cell is a team of designers, engineers, and scientists developing sustainable materials aimed at reducing plastic use and carbon emissions. The company operates in the sustainable materials and climate space.

7 investors

Biomemory develops DNA-based data storage systems for data centers, offering an alternative storage tier optimized for long-term archival, density, and energy efficiency. The company manufactures synthetic DNA storage cards and servers that integrate with existing multi-tier data center architectures to reduce infrastructure costs and environmental impact.

7 investors

CatalYm develops immunotherapies for solid tumors by neutralizing GDF-15, a factor cancer cells use to suppress immune responses and resist treatment. Its lead antibody, visugromab, is being advanced through clinical trials in combination with anti-PD-1 therapies to overcome cancer therapy resistance.

7 investors

CB Therapeutics engineers microbes to biomanufacture high-value natural ingredients used in medicines, supplements, and wellness products. The company builds biological supply chains for rare natural compounds aimed at treating disease and supporting longevity.

7 investors

CellFE develops microfluidics technology and instrumentation for cell therapy manufacturing, serving biotech researchers and clinical teams. The company's platform enables more efficient and accessible production of cell therapies for treatment applications.

7 investors

Cerevance develops precision novel therapeutics for central nervous system disorders, particularly neurodegenerative diseases, using its proprietary NETSseq platform and machine learning to identify targets from an extensive collection of human brain tissue samples. The company has multiple candidates in clinical development targeting Parkinson's disease, psychiatric conditions, ALS, and Alzheimer's disease.

7 investors

Civil Maps develops artificial intelligence for autonomous vehicle perception, creating continental-scale HD 3D maps and centimeter-level localization systems. The company serves the autonomous mobility and automotive industry.

7 investors

Clearpath Robotics builds unmanned vehicles and robotics platforms aimed at making robotics research and development easier for its customers. It serves R&D groups and researchers working on robotics applications, positioning itself in the robotics hardware sector.

7 investors

Code Metal builds AI-assisted code translation and modernization tools that use formal verification and program analysis to produce tested, standards-compliant, and portable code. It targets mission-critical industries such as aerospace, automotive, and defense, helping teams modernize legacy code, avoid chip vendor lock-in, and meet safety and compliance requirements.

7 investors

Cognichip develops Artificial Chip Intelligence (ACI), an AI system designed to accelerate semiconductor design by reducing design effort and time-to-market for chip manufacturers. The platform aims to address the hardware development bottleneck by automating chip design workflows and making the process more accessible to the semiconductor industry.

7 investors

Constructive Bio is a biotechnology company that rewrites the genetic code to give cells access to non-canonical amino acid building blocks, expanding the range of proteins that can be designed, engineered, and manufactured. Its platform aims to move novel molecules from research to industrial-scale production for applications ranging from medicines to advanced materials.

7 investors